HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Ishida Selected Research

Doxorubicin (Adriamycin)

10/2001[Histological evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin/mitomycin C].
10/2000[Hepatic arterial injection of degradable starch microspheres (DSM) combined with adriamycin (ADM) and mitomycin C (MMC) in patients with liver metastasis of colorectal cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Ishida Research Topics

Disease

29Neoplasms (Cancer)
01/2022 - 01/2000
20Neoplasm Metastasis (Metastasis)
12/2013 - 01/2000
12Colorectal Neoplasms (Colorectal Cancer)
12/2013 - 01/2000
11Pneumoperitoneum
04/2005 - 02/2000
9Prostatic Neoplasms (Prostate Cancer)
10/2018 - 11/2000
8Infections
10/2018 - 01/2000
5Lymphatic Metastasis
08/2018 - 01/2000
5Colonic Neoplasms (Colon Cancer)
12/2010 - 03/2000
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2018 - 06/2003
3Carcinoma (Carcinomatosis)
07/2018 - 02/2000
3Hemorrhage
06/2005 - 04/2001
3Necrosis
09/2004 - 07/2000
3Wounds and Injuries (Trauma)
07/2003 - 02/2000
3Breast Neoplasms (Breast Cancer)
10/2001 - 10/2000
3Body Weight (Weight, Body)
09/2001 - 01/2000
3Hepatocellular Carcinoma (Hepatoma)
01/2001 - 01/2000
2Chronic Kidney Failure (Chronic Renal Failure)
12/2018 - 06/2008
2Kidney Diseases (Kidney Disease)
12/2018 - 10/2018
2Human Influenza (Influenza)
10/2018 - 10/2000
2Esophageal Squamous Cell Carcinoma
08/2018 - 07/2018
2Atrophy
01/2017 - 04/2001
2Malignant Pleural Effusion
01/2017 - 10/2004
2Pain (Aches)
01/2016 - 10/2000
2Proteinuria
10/2015 - 10/2001
2Insulin Resistance
03/2007 - 12/2001
2Hypertension (High Blood Pressure)
09/2004 - 10/2001
2Thrombotic Microangiopathies
08/2002 - 11/2001
2Type 2 Diabetes Mellitus (MODY)
12/2001 - 06/2000
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2001 - 08/2001
2Lung Neoplasms (Lung Cancer)
12/2001 - 08/2001
2Left Ventricular Dysfunction
09/2001 - 06/2000
2Heart Failure
09/2001 - 06/2000
2Adenocarcinoma
09/2001 - 01/2000
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
08/2001 - 08/2000
2Osteosarcoma (Osteogenic Sarcoma)
05/2001 - 07/2000
2Cardiomegaly (Heart Hypertrophy)
11/2000 - 09/2000
1Anastomotic Leak
12/2018
1Cysts
10/2018
1Philadelphia Chromosome
08/2018
1Arteritis
12/2017
1Fibrosis (Cirrhosis)
01/2017

Drug/Important Bio-Agent (IBA)

6Carbon DioxideIBA
04/2005 - 03/2000
5Proteins (Proteins, Gene)FDA Link
12/2010 - 11/2000
4Prostate-Specific Antigen (Semenogelase)IBA
10/2018 - 01/2001
4CreatinineIBA
01/2017 - 10/2001
4Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
07/2009 - 10/2000
4Fluorouracil (Carac)FDA LinkGeneric
07/2009 - 10/2000
4C-Reactive ProteinIBA
07/2005 - 08/2000
4Insulin (Novolin)FDA Link
12/2001 - 01/2000
3EnzymesIBA
01/2014 - 10/2000
3Tacrolimus (Prograf)FDA LinkGeneric
01/2014 - 11/2001
3Dihydrotachysterol (AT 10)IBA
08/2003 - 06/2000
3doxifluridineIBA
10/2001 - 02/2000
3AntigensIBA
05/2001 - 07/2000
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 01/2010
2Pharmaceutical PreparationsIBA
01/2014 - 05/2010
2Docetaxel (Taxotere)FDA Link
01/2010 - 10/2001
2AntibodiesIBA
02/2009 - 07/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2007 - 07/2000
2GasesIBA
07/2003 - 02/2001
2A-factor (Streptomyces)IBA
12/2001 - 02/2000
2Thymidine PhosphorylaseIBA
10/2001 - 06/2001
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2001 - 10/2000
2degradable starch microspheresIBA
10/2001 - 10/2000
2Mitomycin (Mitomycin-C)FDA LinkGeneric
10/2001 - 10/2000
2AndrogensIBA
09/2001 - 01/2001
2Messenger RNA (mRNA)IBA
08/2001 - 01/2000
2ImmunosorbentsIBA
06/2001 - 10/2000
2HLA-A24 AntigenIBA
05/2001 - 07/2000
2EpitopesIBA
05/2001 - 07/2000
2Monoclonal AntibodiesIBA
01/2001 - 06/2000
2Epirubicin (Ellence)FDA LinkGeneric
10/2000 - 10/2000
2VX (EDIM)IBA
08/2000 - 02/2000
1Influenza Vaccines (Influenza Vaccine)FDA Link
10/2018
1VaccinesIBA
10/2018
1Vascular Endothelial Growth FactorsIBA
08/2018
1Tyrosine Kinase InhibitorsIBA
08/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2018
1Vascular Endothelial Growth Factor CIBA
08/2018

Therapy/Procedure

16Therapeutics
01/2008 - 01/2000
12Kidney Transplantation
10/2018 - 01/2000
10Laparotomy
12/2010 - 01/2000
8Prostatectomy (Retropubic Prostatectomy)
10/2018 - 08/2000
7Drug Therapy (Chemotherapy)
01/2022 - 10/2001
5Transplantation
12/2018 - 09/2004
5Nephrectomy
10/2018 - 01/2001
5Renal Dialysis (Hemodialysis)
02/2009 - 01/2000
4Anesthesia
02/2004 - 06/2000
3Surgical Instruments (Clip)
06/2003 - 02/2000
2Brachytherapy
10/2018 - 04/2016
2Chemoradiotherapy
07/2018 - 01/2010
2Radiotherapy
04/2016 - 01/2010
2Lymph Node Excision (Lymph Node Dissection)
06/2010 - 01/2001
2Hematopoietic Stem Cell Transplantation
10/2007 - 01/2006
2Stem Cell Transplantation
01/2006 - 08/2004
2Aftercare (After-Treatment)
09/2001 - 11/2000
2Immunotherapy
05/2001 - 07/2000
1Esophagectomy
12/2018
1Erythrocyte Transfusion
10/2018
1Organ Transplantation
10/2018